Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery in soft tissue sarcomas

A Azzarelli1

  • 1Sezione dei Tumori Muscolo-Scheletrici of the Divisione di Oncologia Chirurgica A, Istituto Nazionale Tumori, Milano, Italy.

European Journal of Cancer (Oxford, England : 1990)
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas.

Oncology reports·2011
Same author

SYT-SSX fusion genes and prognosis in synovial sarcoma.

British journal of cancer·2001
Same author

Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.

Cancer·2001
Same author

c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.

British journal of cancer·2001
Same author

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

European journal of cancer (Oxford, England : 1990)·2001
Same author

Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.

International journal of cancer·2001
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Surgical treatment for soft tissue sarcomas has improved, but local recurrence remains a challenge. Key factors influencing recurrence include tumor grade, location, prior treatment, and surgical margin quality.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Pathology

Background:

  • Soft tissue sarcoma treatment has advanced, yet unified procedures and indications are lacking.
  • Significant discrepancies in reported local recurrence rates persist, even in major centers.
  • Predictive factors for regional control include lesion size, location, grade, prior treatment, and surgical margins.

Purpose of the Study:

  • To analyze regional control results from 417 soft tissue sarcoma cases treated between 1974-1984.
  • To identify factors impacting local recurrence rates in surgical treatment of soft tissue sarcomas.
  • To propose a rationale for surgical indications based on analyzed parameters.

Main Methods:

  • Retrospective analysis of 417 soft tissue sarcoma cases.

Related Experiment Videos

  • Evaluation of local failure rates based on pathological grading, tumor site, previous treatments, and surgical margin quality.
  • Stratification of histopathology into four categories influencing treatment.

    • Main Results:

    • A crude local failure rate of 27% (31% actuarial risk at 5 years) was observed.
    • High-grade sarcomas (35%) showed higher recurrence than low-grade (24%).
    • Trunk/head/neck (47%) and marginal surgical margins (47%) were associated with increased recurrence compared to extremity/girdle (26%) and adequate margins (24%).

    Conclusions:

    • Surgical margin quality is a critical factor in preventing local recurrence.
    • Tumor grade, location, and prior treatment also significantly impact regional control.
    • A structured rationale for surgical indication, considering these parameters, is proposed.